Wells Fargo Initiates Coverage On Disc Medicine with Overweight Rating, Announces Price Target of $75
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo has initiated coverage on Disc Medicine (NASDAQ:IRON) with an Overweight rating and set a price target of $75.
August 22, 2024 | 12:53 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has initiated coverage on Disc Medicine with an Overweight rating and a price target of $75, indicating a positive outlook.
The initiation of coverage with an Overweight rating and a specific price target by a major financial institution like Wells Fargo is likely to positively influence investor sentiment and could lead to an increase in the stock price of Disc Medicine in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100